Buy Crypto Markets Spot FuturesBTC Earn Event Centre Rewards Hub

Genelux Corporation (GNLX)

NASDAQ

$2.51

$+0.01

(+0.36%)

Pre-Market

Genelux Corporation (GNLX) Live Price Chart

Last updated: ⁦2026-09-16 11:04:40⁩. Prices reflect the latest pre-market trading data. Stock price data is sourced from Massive.

Summary

Genelux Corporation (GNLX) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $2.51, with a market capitalisation of $114.92M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $2.29 to $8.54. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$114.92M
Open	$2.51
Day's High	$40.98
Day's Low	$1.60
Previous Close	$2.47
Volume	44.00
Average Volume	269.15K
P/E Ratio	--
52-Week High	$8.54
52-Week Low	$2.29
Dividend Yield	--
Earnings Date	--

Genelux Corporation (GNLX) Pre-Market Stock Price

Genelux Corporation (GNLX) is trading at $2.51 in pre-market trading as of 2026-09-16 11:01:00, up 1.78% ($0.04) from the previous close of $2.47

Pre-market trading shows how investors are pricing GNLX before the regular session opens. The current pre-market price is above the previous close, indicating positive early trading sentiment.

Genelux Corporation (GNLX) 7-Day Stock Price Change

Over the past seven days, Genelux Corporation (GNLX) moved from $2.44 to $2.51, representing a gain of 3.03% ($0.07).

The stock traded between $2.39 and $2.73 during the period. The latest price is near the middle of the 7-day range, indicating moderate upward.

The average daily volume was 286.06 thousand shares, down versus the previous seven-day period, indicating lower trading activity.

GNLX 52-Week Price Position

Position in Range: 3.6%

52W Low$2.29

52W High$8.54

GNLX is currently trading at $2.51, placing it 3.6% of the way from its 52-week low of $2.29 to its 52-week high of $8.54. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Genelux Corporation (GNLX)?

Genelux Corp is a late-stage biopharmaceutical firm focused on developing oncolytic viral immunotherapies for cancer. Its pipeline includes clinical and preclinical candidates designed to target tumor cells and stimulate an immune response against tumor-specific antigens. The company is focused on the development of next-generation oncolytic viral immunotherapies that are designed to generate a personalized multi-prong attack to overwhelm a tumor's sophisticated defense mechanisms.

Genelux Corporation Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	26
Exchange	NASDAQ
Company Website	https://www.genelux.com

How to Buy Genelux Corporation (GNLX) Stock on MEXC

Eligible investors can buy real shares of Genelux Corporation (GNLX) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licenced broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for GNLX and Place Your Order

Open the RealStocks trading page and search for GNLX. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Genelux Corporation (GNLX) stock price today?

Genelux Corporation (GNLX) is currently trading at $ 2.51, up 1.78% ($0.04) from the previous close of $ 2.47. Intraday prices update in real time during regular trading hours.

2.Is GNLX stock going up or down today?

As of 2026-09-16 11:01:00, GNLX is trading at $ 2.51, up 1.78% ($0.04) from its previous close of $ 2.47. The stock has traded between $ 1.60 and $ 40.98 during today’s regular session. Past price movements do not guarantee future results.

3.What is GNLX pre-market price?

As of 2026-09-16 11:01:00, GNLX is trading at $ 2.51 in pre-market trading, up 1.78% ($0.04) from the previous close of $ 2.47. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is GNLX after-hours price?

As of 2026-09-16 11:01:00, GNLX is trading at $ 2.51 in after-hours trading, up 1.42% ($0.03) from the regular-session close of $ 2.47. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is GNLX stock trading now?

GNLX trades on the NASDAQ exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does GNLX sit relative to its 52-week high and low?

Over the past 52 weeks, GNLX has traded between a low of $ 2.29 and a high of $ 8.54. At $ 2.51, the stock is positioned 3.6% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Genelux Corporation in?

Genelux Corporation (GNLX) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Genelux Corporation's market capitalisation and where is it listed?

Genelux Corporation is listed on the NASDAQ exchange with a market capitalisation of $ 114.92M. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is GNLX valued in terms of P/E ratio and EPS?

GNLX trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -0.79. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Genelux Corporation pay a dividend?

Genelux Corporation pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.